As of 2025-08-25, the Fair Value of Homology Medicines Inc (QTTB) is -24.49 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.91 USD, the upside of Homology Medicines Inc is -1,382.34%.
With the market price of 1.91 USD and our fair value calculation, Homology Medicines Inc (QTTB) is not a good investment. Investing in QTTB stocks now will result in a potential loss of 1,382.34%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -128.69 | -95.76 | -5.01 | -112.96 | -47.73 | -78.03 |
| YoY growth | -23.84% | 25.59% | 94.77% | -2,154.71% | 57.74% | -400.09% |
| Market Cap (mil) | 23.30 |
| P/E | |
| Forward P/E |
| EPS | -4.90 |
| Avg earnings growth rate | -400.09% |
| TTM earnings | -59.76 |